EmRELIS

The Ask

Revolutionary new drug that will target late stage lung cancer for oncologists and help give patients more time via C-Met protein overexpression to target NSCLC.

The Idea  

Emphasizing the oncologist’s inner nerd to craft engaging metaphors that illustrate how the drug targets C-Met protein overexpression—without sounding morose.